Chimeric Therapeutics Limited (CHMMF)
Chimeric Therapeutics Limited is an Australian biotechnology firm operating at the clinical stage, dedicated to advancing and commercializing a diverse portfolio of cell-based treatments specifically for cancer. Its pipeline features several promising candidates. CHM 0201, utilizing a core natural killer (NK) cell platform, is currently undergoing Phase I clinical trials for the treatment of both solid tumors and hematological malignancies. Another key program, CHM 1101 (a CLTX CAR T-cell therapy), is also in Phase I development, specifically targeting patients with recurrent or progressive glioblastoma that expresses MMP2. Beyond these lead programs, the company is actively developing a range of other innovative therapies. These include CHM 0301 for various blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK), both designed to combat solid tumors. The CLTX CAR T-cell therapy, CHM 1101, is additionally being explored for indications such as melanoma, colorectal, and prostate cancers. Furthermore, CHM 2101 (CDH17 CAR T) is under development for neuroendocrine, colorectal, pancreatic, and gastric cancers. Established in 2020, Chimeric Therapeutics Limited maintains its headquarters in Carlton, Australia.
Sector: Biotechnology
Industry: Biotechnology
Chimeric Therapeutics Limited
Nasdaq bars a compliance period at 1:250
- 1:100Reverse splitApr 22, 2026100 shares → 1
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Revenue | $0 | $2.68M | $0 | $3.04M | $1.77M | $0 | $0 |
| YoY Growth | - | - | - | 72.2% | - | - | - |
| Cost of Revenue | $0 | $572K | $3K | $0 | $642K | $572K | $0 |
| Gross Profit | $0 | $2.11M | -$3K | $3.04M | $1.13M | -$572K | $0 |
| Gross Margin | - | 78.7% | - | 100.0% | 63.7% | - | - |
| Research and Development | $2.3M | $6.6M | $7.53M | $9.75M | $4.13M | $2.55M | $0 |
| Selling, General, and Administrative | $3.33M | $4.76M | $6.46M | $8.06M | $7.48M | $4.17M | $43K |
| Other | $0 | $959K | $0 | $2.12M | $0 | $3.49M | $0 |
| Total Operating Expenses | $5.64M | $12.32M | $14M | $19.92M | $11.61M | $10.21M | $43K |
| Operating Income (EBIT) | -$5.64M | -$10.21M | -$14M | -$16.94M | -$10.2M | -$10.21M | -$43K |
| Operating Margin | - | -380.8% | - | -556.6% | -576.7% | - | - |
| Interest Expense | $0 | $143K | $224K | $523K | $433K | $4K | $0 |
| Interest Income | $26K | $32K | $82K | $19K | $9K | $2K | $0 |
| Other Income (Expense) | -$7.04M | $3.24M | -$348K | -$223K | -$424K | -$2K | $2 |
| Income Before Tax (EBT) | -$12.68M | -$6.97M | -$14.35M | -$17.17M | -$10.63M | -$10.21M | -$43K |
| Income Tax Expense | $15K | $75K | -$5.88M | $63K | $111K | $0 | $0 |
| Net Income | -$12.69M | -$7.05M | -$8.47M | -$17.23M | -$10.74M | -$10.21M | -$43K |
| Net Income Margin | - | -262.8% | - | -566.0% | -607.5% | - | - |
| Supplementary Data | |||||||
| EPS | -0.61 | -0.77 | -1.80 | -5.89 | -4.42 | -4.64 | -0.02 |
| Diluted EPS | -0.61 | -0.77 | -1.80 | -5.89 | -4.42 | -4.64 | -0.02 |
| Weighted Average OS | 30.85M | 13.52M | 6.96M | 4.33M | 3.60M | 3.26M | 3.43M |
| EBITDA | -$5.64M | -$6.13M | -$7.58M | -$16.23M | -$9.2M | -$9.64M | $104K |
| EBITDA Margin | - | -228.7% | - | -533.0% | -520.5% | - | - |
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $540K | $3.89M | $2.06M | $1.6M | $12.42M | $15.14M | $68 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $540K | $3.89M | $2.06M | $1.6M | $12.42M | $15.14M | $68 |
| Accounts Receivable | $20K | $3.08M | $59K | $4.5M | $27K | $16K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $132K | $147K | $56K | $223K | $1.86M | $156K | $0 |
| Total Current Assets | $691K | $7.11M | $2.18M | $6.32M | $14.3M | $15.31M | $68 |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $0 | $0 | $463 | $4K | $11K | $9K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $172K | $7.46M | $8.11M | $8.77M | $9.22M | $9.34M | $9.34M |
| Long-Term Investments | $0 | $0 | $27K | $27K | $27K | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $172K | $7.46M | $8.14M | $8.8M | $9.26M | $9.35M | $9K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | -$9.34M |
| Total Assets | $863K | $14.57M | $10.32M | $15.12M | $23.57M | $24.67M | $68 |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $3.64M | $4.44M | $2.16M | $5M | $3.18M | $1.38M | $0 |
| Short-Term Debt | $459K | $0 | $2.43M | $0 | $0 | $0 | $23K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $1.74M | $2.53M | $2.64M | $2.62M | $1.79M | $2.92M | $20 |
| Total Current Liabilities | $6M | $9.87M | $9.25M | $9.93M | $6.1M | $4.97M | $43 |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $76K | $3.37M | $1.83M | $1.37M | $103K | $2.72M | $0 |
| Total Long-Term Liabilities | $76K | $3.37M | $1.83M | $1.37M | $103K | $2.72M | $0 |
| Other Liabilities | $0 | $0 | -$2.43M | $0 | $0 | $0 | $0 |
| Total Liabilities | $6.07M | $13.24M | $8.65M | $11.29M | $6.2M | $7.69M | $43K |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $54.26M | $47.41M | $42.91M | $36.44M | $35M | $25.25M | $68 |
| Retained Earnings | -$63.81M | -$51.58M | -$44.97M | -$38.36M | -$20.85M | -$10.26M | -$43K |
| Comprehensive Income & Other | $4.34M | $5.5M | $3.73M | $5.75M | $3.22M | $1.99M | $0 |
| Other Stockholders' Equity | $4.34M | $5.5M | $3.73M | $5.75M | $3.22M | $1.99M | -$1 |
| Total Equity | -$5.21M | $1.33M | $1.67M | $3.82M | $17.37M | $16.98M | -$43K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $863K | $14.57M | $10.32M | $15.12M | $23.57M | $24.67M | $67 |
| Supplementary Data | |||||||
| Total Debt | $459K | $0 | $2.43M | $0 | $0 | $0 | $23K |
| Net Debt | -$81K | -$3.89M | $366K | -$1.6M | -$12.42M | -$15.14M | $23 |
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Operating Activities | |||||||
| Net Income | -$12.69M | -$7.05M | -$8.47M | -$17.51M | -$10.74M | -$10.21M | -$43K |
| Depreciation & Amortization | $0 | $697K | $731K | $652K | $642K | $572K | $104K |
| Deferred Income Tax | $0 | $0 | $0 | -$1.02M | -$4.99M | -$832K | $0 |
| Stock-Based Compensation | $0 | $734K | $604K | $2.24M | $2.14M | $1.42M | $0 |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $0 | -$9K | $2.41M | -$671K | -$1.78M | -$16K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $3.2M | $218K | $1.75M | $0 |
| Other Working Capital | $0 | -$136K | $10K | $68K | $67K | -$156K | $20K |
| Total Working Capital Change | $0 | -$145K | $2.42M | $2.6M | -$1.49M | $1.58M | $20K |
| Other Non-Cash Items | $5.42M | $845K | -$380K | $2.01M | $5.55M | $1.5M | -$104K |
| Net Cash from Operating | -$7.28M | -$4.92M | -$5.09M | -$11.02M | -$8.89M | -$5.97M | -$23K |
| Investing Activities | |||||||
| Capital Expenditures | -$168K | $0 | $0 | -$76K | -$363K | -$3.59M | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | -$27K | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$76K | $9K | $2K | $0 |
| Net Cash from Investing | -$168K | $0 | $0 | -$76K | -$382K | -$3.58M | $0 |
| Financing Activities | |||||||
| Debt Repaid | $607K | - | $1.54M | $1.5M | $2.76M | $23K | - |
| Common Stock Issuance | $5.33M | $5.54M | $7.93M | $1.74M | $10.07M | $24.72M | $68 |
| Common Stock Repurchases | $0 | $0 | -$808K | -$60K | -$884K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$617K | $6.79M | -$7K | -$7K | -$1.89M | -$6K | $23K |
| Net Cash from Financing | $4.1M | $6.79M | $5.58M | $171K | $6.42M | $24.69M | $23K |
| Forex Effect | $188K | -$44K | -$19K | $98K | $110K | $6K | $0 |
| Net Change in Cash | -$3.15M | $1.83M | $466K | -$10.82M | -$2.72M | $15.14M | $68 |
| Supplementary Data | |||||||
| Operating Cash Flow | -$7.28M | -$4.92M | -$5.09M | -$11.02M | -$8.89M | -$5.97M | -$23K |
| Capital Expenditure | $7.28M | $0 | $0 | -$76K | -$363K | -$3.59M | $0 |
| Free Cash Flow | $0 | -$4.92M | -$5.09M | -$11.1M | -$9.25M | -$9.56M | -$23K |
| Cash at Beginning | $3.69M | $2.06M | $1.6M | $12.42M | $15.14M | $68 | $0 |
| Cash at End | $540K | $3.89M | $2.06M | $1.6M | $12.42M | $15.14M | $68 |